Industries with workers who routinely work outdoors in the midwestern and southeastern United States should consider providing worker training and education to enhance awareness of Blastomyces, the ...
Fosravuconazole is under clinical development by Eisai and currently in Phase III for Fungal Infections. According to GlobalData, Phase III drugs for Fungal Infections have a 53% phase transition ...
INR:8239. microgaming white label Vertex Begins Phase 1/2 Clinical Trial of VX-880 Experimental Treatment Common fungi in the intestine can induce an immu ...